Amantadine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Amantadine and local guidelines before prescribing.

Antiparkinsonian

Mechanism

NMDA antagonist with dopaminergic effects and antiviral action.

Uses

Parkinson dyskinesia, fatigue in MS, influenza (rarely).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Confusion, hallucinations, livedo reticularis, ankle oedema, insomnia.

Interactions

Anticholinergics additive; memantine.

Contraindications and cautions

Epilepsy, severe renal impairment

Monitoring

Cognition

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose if CrCl below 60

Overdose and reversal

Supportive

Special advice

Avoid evening dosing; reduce in renal impairment.

More from the textbook: uses, cautions and other points
Where it is discussed in the book